InterShunt (Undisclosed)
Funding Details
- Awarder
- Inbox
- Date Award
- January 11, 2021
- Vertical
- Medical Devices
- Funding URL
- View Funding Page
Company Info
- Founders
- Harlee Sorkin
- Company Description
- InterShunt is developing a proprietary catheter system that allows for the capture and excision of tissue from the interatrial septum. The result is a left to right atrial shunt that off-loads elevated left atrial pressure, reducing symptoms in Heart Failure patients. The mechanical system is designed for safety and ease of use and is the only interatrial shunting device that requires no implant and no energy.
- Market
- Heart Failure Treatment
- Location
- St. Louis, MO, USA
- Coinvestors
- Arsenal Capital Management, Solas Bioventures